Main > CARDIOLOGY > Co: USA. B. Arrhytmia>AF>NVAF> *



Co: USA. B. Arrhytmia>AF>NVAF> *'s subsections
(*) EU Approval Date: 2012. 11.20
(*) USA Approval Date: 2013. 02.01
>Stroke/Syst Embolism>Risk Redn
Apixaban Tab.
Company
Company Partner
Oral Factor Xa Inhibitor AntiCoagul
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 14
Patent>UpDate: 2018. 01.23
TradeMark
TradeMark Web-Site

Co: USA. B. Arrhytmia>AF>NVAF> *'s products
This section has no products